Dr. Chukwunyelu Enwezor, MD

Dr. Enwezor practices at Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health.

Dr. Enwezor's NPI, 1740545185, was assigned on July 11, 2012. Dr. Enwezor holds South Carolina license 87526.

Dr. Enwezor's primary practice is Prisma Health Greenville Memorial Hospital, at 701 Grove Road, Greenville, SC 29605 in Greenville County. The practice phone is (864) 455-7000.

Dr. Enwezor's primary practice is Prisma Health Greenville Memorial Hospital in Greenville, South Carolina, part of Prisma Health. Dr. Enwezor is also affiliated with Bon Secours St. Francis Downtown. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Enwezor to 3 more hospitals, 7 medical groups and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Enwezor practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Enwezor's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Enwezor's licenses on file in 2 states: South Carolina and Georgia.

CMS data shows 285 Medicare services from Dr. Enwezor across 5 procedure codes in 2024, for 209 Medicare patients. Medicare paid $26,066 for them.

CMS counts 209 Medicare patients who saw Dr. Enwezor in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Enwezor's median patient age at 62, with 47% women.

In 2024, Dr. Enwezor wrote 321 Medicare Part D claims for 92 patients. 72% of them were for generic drugs. CMS names the drug for 153 of them, across 6 drugs with 11 or more claims each, at $170,738 in total drug cost. In 2023, CMS named 220 claims across 11 drugs.

Dr. Enwezor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Enwezor as offering telehealth.

CMS Open Payments shows 59 general payments to Dr. Enwezor from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Astellas Pharma US Inc paid the most, $310.